About Us

Navia’s Clinical Research brings together experienced investigators, registered nurses, clinical research coordinators, phlebotomy and investigational-product support in a dedicated outpatient research setting. Our bilingual English- and Spanish-speaking team works with participants, physicians, sponsors, and CROs to support ethical study conduct, participant safety, protocol compliance, and high-quality data throughout the research process.

Coromoto Angela Palermo, MD — Endocrinology, Diabetes & Metabolism

Alfredo Lam, DO — Family Medicine

José Carlos Pedraza Navia, RN—Site Manager & Clinical Research Coordinator

Olga Lidia Navia Corrales, RN—Site Operations Director & Clinical Research Coordinator

Nayiver Pedraza Haquim—Clinical Research Phlebotomist & Medical Assistant

Mario Enrique Hernandez—Clinical Research Pharmacy Technician & Investigational Product Coordinator

For us, excellence in research means careful protocol execution, active investigator oversight, accurate documentation, responsive communication, and respect for every participant. Our team is committed to providing a supportive research experience while maintaining the quality and regulatory standards expected by sponsors and CROs.

From initial screening through study completion, we focus on clear communication, participant safety, reliable follow-up, and consistent study execution.

Our mission is to expand access to ethical, participant-centered clinical research while supporting high-quality study execution for sponsors and CROs. Through experienced investigators, bilingual clinical staff, and thoughtful study selection, we work to connect our South Florida community with meaningful research opportunities while protecting participant welfare and data integrity.

Our vision is to become a trusted clinical research partner in South Florida, recognized for reliable study execution, responsive investigator access, strong participant engagement, and transparent collaboration with sponsors and CROs. We aim to build lasting research partnerships by selecting studies that align with our investigators, patient population, and operational capabilities.